# A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

> **NCT06094010** · PHASE3 · RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 1100 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Baloxavir Marboxil

## Key facts

- **NCT ID:** NCT06094010
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-22
- **Primary completion:** 2027-05-11
- **Final completion:** 2027-06-30
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06094010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06094010, "A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06094010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*